Advertisement
DBD vs GDRX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBD is a Buy and GDRX is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DBD’s FA Score shows that 0 FA rating(s) are green whileGDRX’s FA Score has 0 green FA rating(s).
- DBD’s FA Score: 0 green, 5 red.
- GDRX’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DBD’s TA Score shows that 4 TA indicator(s) are bullish while GDRX’s TA Score has 5 bullish TA indicator(s).
- DBD’s TA Score: 4 bullish, 4 bearish.
- GDRX’s TA Score: 5 bullish, 4 bearish.
Price Growth
DBD (@Packaged Software) experienced а +4.27% price change this week, while GDRX (@Services to the Health Industry) price change was -5.73% for the same time period.
The average weekly price growth across all stocks in the @Packaged Software industry was -4.81%. For the same industry, the average monthly price growth was -0.32%, and the average quarterly price growth was -13.41%.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -5.80%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was -6.65%.
Reported Earning Dates
DBD is expected to report earnings on Jul 29, 2026.
GDRX is expected to report earnings on Aug 05, 2026.
Industries' Descriptions
@Packaged Software (-4.81% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
@Services to the Health Industry (-5.80% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
| DBD | GDRX | DBD / GDRX | |
| Capitalization | 3.09B | 999M | 310% |
| EBITDA | 357M | 173M | 206% |
| Gain YTD | 31.581 | 9.225 | 342% |
| P/E Ratio | 30.80 | 49.17 | 63% |
| Revenue | 3.86B | 788M | 489% |
| Total Cash | 374M | 236M | 158% |
| Total Debt | 939M | 541M | 174% |
GDRX | ||
|---|---|---|
OUTLOOK RATING 1..100 | 88 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 67 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 89 | |
PRICE GROWTH RATING 1..100 | 47 | |
P/E GROWTH RATING 1..100 | 82 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| DBD | GDRX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 80% | 2 days ago 63% |
| Stochastic ODDS (%) | 2 days ago 73% | 2 days ago 84% |
| Momentum ODDS (%) | 2 days ago 84% | 2 days ago 86% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 75% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 79% |
| TrendMonth ODDS (%) | 2 days ago 79% | 2 days ago 81% |
| Advances ODDS (%) | 9 days ago 81% | 9 days ago 79% |
| Declines ODDS (%) | 3 days ago 57% | 3 days ago 82% |
| BollingerBands ODDS (%) | 2 days ago 63% | 2 days ago 76% |
| Aroon ODDS (%) | 2 days ago 76% | 2 days ago 80% |
Advertisement
DBD and
Correlation & Price change
A.I.dvisor indicates that over the last year, DBD has been loosely correlated with GDRX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DBD jumps, then GDRX could also see price increases.
| Ticker / NAME | Correlation To DBD | 1D Price Change % | ||
|---|---|---|---|---|
| DBD | 100% | +2.70% | ||
| GDRX - DBD | 49% Loosely correlated | +3.14% | ||
| RAMP - DBD | 47% Loosely correlated | -0.03% | ||
| BLZE - DBD | 43% Loosely correlated | -9.01% | ||
| EEFT - DBD | 42% Loosely correlated | +2.61% | ||
| PAYO - DBD | 41% Loosely correlated | N/A | ||
More | ||||